NCT01578941

An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: University of Alabama at Birmingham · Academic / Other
• Sex: Female
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The study is to primarily investigate whether Treximet® (Imitrex RT/naproxen sodium 500mg) taken at the first onset of menstrual migraine will both terminate the acute headache and assist in preventing headache recurrence and the need for repeat abortive therapy over the ensuing days of menses.

Conditions

• Menstrual Migraine

Interventions

Type	Name	Description
OTHER	Diary	Each subject will be asked to keep a careful headache diary (appendix B) , and in that diary she will record onset and cessation of menstrual flow, days of menstrual headache (and "migraine" headache, specifically) experienced, days of functionally incapacitating headache experienced, any abortive/symptomatic medications taken, any days of work-related absenteeism (\>4 hrs) related to acute MM headache and any unscheduled visits to a medical facility for acute treatment of MM.

Timeline

• Start date: 2011-01-01
• Primary completion: 2012-09-01
• Completion: 2012-09-01
• First posted: 2012-04-17
• Last updated: 2012-11-01

Locations

1 site across 1 country: United States